TP53 and cancer: In contrast to DFT1 and DFT2, the non-transmissible carcinoma carries recognisable driver mutations in well-characterised cancer genes (E542K PIK3CA mutation amplified to more than sixty copies; TP53 truncation; NOTCH2 mutations) (Table S6, Table S7; see Figure 5A).